The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.

A company that formulates pharmaceuticals in a sterile environment is spending almost $30 million to expand its headquarters ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

Eramol’s purpose-built sterile manufacturing facility at the Sevenoaks campus is in the final stages of commissioning and ...

LEE — In the past several years, Berkshire Sterile Manufacturing has been significantly increasing its capabilities and expanding its potential market. This has included the development of two new ...

Dalton Pharma Services today announced that it has expanded it cGMP sterile powder filling capabilities as part of its ongoing focus of sterile manufacturing, supported by FedDev Ontario funding.

LEE — Berkshire Sterile Manufacturing is putting the finishing touches on its new, state-of-the-art production line, the centerpiece of the firm’s $20 million expansion project. But receiving and ...

Sterile manufacturing refers to the method of producing medications in which the drug product, container, and closure are meticulously sterilized before being distributed. The pharmaceutical sector ...

CMO's Nottingham site first to use EmulTech's ET4ME technology for GMP production of pharmaceuticals Newcastle and Eindhoven, 18 February, 2013: Aesica, the global contract manufacturing organisation ...

ALBANY, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million ...

DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that ...

According to the National Cancer Institute, immunotherapies that enlist and strengthen the power of a patient’s immune system are the “fifth pillar” of cancer treatment adding to surgery, chemotherapy ...